Abstract: Disclosed are improved devices, systems, methods and compositions containing therapeutic lipid monolayer stabilized gas microfoam(s) that can be applied to the skin after a treatment which “damages” or otherwise modifies one or more skin layers, which can improve a patient's recovery time, reduce swelling, scarification and/or callous formation, reduce skin sensitivity and/or lead to a more desirable appearance in a shorter period of time than existing skin treatments.

Abstract: Disclosed are improved devices, systems and methods of delivering oxygen and/or other therapeutic substances into and/or through the skin of a living organism, such as a mammal and/or human patient, by applying compounds incorporating microbubble carriers to the external surface of the individual's skin.